B2M and HIV infectious disease: Considering that nearly half of the B2M in plasma originates from lymphocytes, and that lymphocyte activation significantly boosts B2M production (Swanson et al. 1982; Kin et al. 1979), it is reasonable to hypothesize that the heightened B2M levels in AIDS patients result from activated lymphocytes following HIV infection.